Thailand Organ Transplant Immunosuppressant Drugs Market Size & Outlook
Related Markets
Thailand organ transplant immunosuppressant drugs market highlights
- The Thailand organ transplant immunosuppressant drugs market generated a revenue of USD 34.5 million in 2024 and is expected to reach USD 44.7 million by 2030.
- The Thailand market is expected to grow at a CAGR of 4.4% from 2025 to 2030.
- In terms of segment, calcineurin inhibitors was the largest revenue generating drug class in 2024.
- Calcineurin Inhibitors is the most lucrative drug class segment registering the fastest growth during the forecast period.
Organ transplant immunosuppressant drugs market data book summary
| Market revenue in 2024 | USD 34.5 million |
| Market revenue in 2030 | USD 44.7 million |
| Growth rate | 4.4% (CAGR from 2025 to 2030) |
| Largest segment | Calcineurin inhibitors |
| Fastest growing segment | Calcineurin Inhibitors |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Calcineurin Inhibitors, Antiproliferative Agents, MTOR Inhibitor, Steroids, Other Drug Classes |
| Key market players worldwide | Astellas Pharma Inc, Sanofi SA, Novartis AG ADR, Dr Reddy's Laboratories Ltd ADR, Roche, GlaxoSmithKline, Asahi Kasei Corp, Bristol-Myers Squibb Co, Accord Healthcare, Viatris Inc |
Other key industry trends
- In terms of revenue, Thailand accounted for 0.6% of the global organ transplant immunosuppressant drugs market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China organ transplant immunosuppressant drugs market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 456.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Organ Transplant Immunosuppressant Drugs Market Scope
Organ Transplant Immunosuppressant Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Accord Healthcare | View profile | 251-500 | Durham, North Carolina, United States, North America | https://www.accordhealthcare.us/ |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | http://www.roche.com |
| Asahi Kasei Corp | View profile | 48897 | 1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo, Japan, 101-8101 | http://www.asahi-kasei.co.jp |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Dr Reddy's Laboratories Ltd ADR | View profile | 22822 | 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, India, 500 034 | https://www.drreddys.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Thailand organ transplant immunosuppressant drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to organ transplant immunosuppressant drugs market will help companies and investors design strategic landscapes.
Calcineurin inhibitors was the largest segment with a revenue share of 41.45% in 2024. Horizon Databook has segmented the Thailand organ transplant immunosuppressant drugs market based on calcineurin inhibitors, antiproliferative agents, mtor inhibitor, steroids, other drug classes covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Thailand organ transplant immunosuppressant drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Thailand organ transplant immunosuppressant drugs market databook
-
Our clientele includes a mix of organ transplant immunosuppressant drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand organ transplant immunosuppressant drugs market, including forecasts for subscribers. This country databook contains high-level insights into Thailand organ transplant immunosuppressant drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Thailand organ transplant immunosuppressant drugs market size, by drug class, 2018-2030 (US$M)
Thailand Organ Transplant Immunosuppressant Drugs Market Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
